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Abstract 
 
Stem cell based therapies serve as a potential option to treat a variety of organ 
dysfunctions such as Parkinson’s, Alzheimer’s, cardiovascular, and musculoskeletal 
diseases because stem cells can be coaxed to differentiate into many types of more 
specialized cells. However, it is challenging to control the niches including bio-chemical 
and mechanical factors that regulate the proliferation and differentiation of stem cells.  
One potential way to resolve this challenge is to encapsulate stem cells in 3D 
biocompatible matrices of various core compositions. In this project, we successfully 
encapsulated human embryonic palatal (HEPM) stem cells in microcapsules with a 3D 
collagen core matrix and alginate shell using a novel multilayer microfluidic chip. This 
was done by creating a device that shears cell suspension and alginate flow using mineral 
oil flow infused with calcium ion to solidify alginate. Studies were conducted to illustrate 
how stiffness and fiber geometry of the collagen core matrix affect cell viability and 
proliferation in the core-shell hydrogel microcapsules. These stem cell laden 
microcapsules could be very useful for cell-based therapy and regenerative medicine 
applications. 
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Chapter 1:  Background 
 
 Stem cells encapsulated in a microcapsule composed of natural polymers like 
alginate can serve as a potential option in cell based therapies to treat a variety of organ 
dysfunctions such as osteoarthritis, Parkinson’s, Alzheimer’s, and cardiovascular diseases 
[1]. Encapsulated stem cells can differentiate into desired cell types like osteoblasts, 
neurons or cardiac cells to aid in rebuilding diseased bone, brain, and heart tissues, 
respectively. It has been hypothesized that differentiated stem cells have the potential to 
speed the recovery of the tissues or organs [2]. However, differentiation of stem cells into 
a desired cell type is not straightforward. There are various factors collectively called the 
“stem cell niche” that determines the fate of stem cells, including soluble chemicals and 
cell-cell and cell-matrix interactions [2,3]. These interactions, however, can be modulated 
by regulating the size and stiffness of alginate microcapsules. For instance, stem cells 
encapsulated in microcapsules composed of a stiff matrix are reported to differentiate into 
osteocytes [4]. Therefore, controlling the size and stiffness of microcapsules is very 
important in managing the differentiation of stem cells into a desired cell type.  
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Chapter 2: Project Introduction 
 
With today’s obesity epidemic, aging baby boomer population, and increased life 
expectancy, a more effective treatment is needed to increase the quality of life of the 
already 27 million victims of osteoarthritis (OA) [5]. Current treatments for OA include 
invasive surgery and implantation, temporary over-the-counter pain relievers, and severe 
lifestyle changes that limit patient mobility [6]. Human embryonic palatal mesenchyme 
(HEPM) stem cells are osteoblast precursor cells that have potential to treat 
osteoimmunological bone disorders like OA due to their calcium and phosphorus 
deposition properties [7,8]. As mesenchymal stem cells differentiate based on the 
stiffness of their environment, HEPM stem cells best mimic in-vivo behavior when in 
contact with a matrix of a high modulus of elasticity [4].  
Type I collagen is the most abundant extracellular matrix protein found in 
connective tissues. Collagen fibers form when monomers polymerize to form 3D 
structures by means of self assembly. The mechanical properties of collagen can vary 
with changing pH, collagen concentration, and ionic strength. By manipulating collagen 
concentrations from 0.3 mg/mL to 3.0 mg/mL, the stiffness of a matrix can vary from 1.5 
to 24.3 kPa, respectively [9]. Because of this, varying collagen concentration is an 
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excellent method to alter matrix stiffness in order to analyze HEPM stem cell 
proliferation. 
 HEPM stem cell proliferation can be studied in varying collagen concentrations 
via either 2D or 3D cell culturing systems. Though 2D cell culturing is easily performed 
and cost effective, the unnatural environment can alter cell morphology, gene and protein 
expression, and cell proliferation and differentiation. 3D cell culturing is advantageous 
because it more closely recapitulates the in-vivo environment experienced by the HEPM 
stem cells.  
In this project, a polydimethylsiloxane (PDMS) based microfluidic device was 
fabricated to produce core (collagen)-shell (alginate) microcapsules of various collagen 
concentrations by employing flow focusing principles. The core-shell microcapsules 
enable cells to be encapsulated in collagen matrices that closely resemble in-vivo 
environments compared to traditional techniques that encapsulate cells in a uniform 
alginate matrix. This device uses mineral oil infused with calcium chloride to shear both 
cell suspension (with collagen) and alginate flows, solidifying alginate in the process. 
HEPM stem cells were successfully encapsulated in these core-shell microcapsules of 
varying stiffness of 3D core matrix. Further, studies were conducted to illustrate how 
stiffness and fiber geometry of the collagen core matrix affect cell viability and 
proliferation in the microcapsules. 
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Chapter 3:  Materials and Methods  
Core-Shell Microfluidic Device Fabrication 
 To create the multilayer microfluidic device, a silicon master was fabricated using 
photo lithography at the Nanotech West facility at The Ohio State University. 
Photosensitive epoxy (SU-8 3050, Microchem) was spin-coated onto 5 inch wafers 
previously cleaned with nitrogen gas and etched for alignment ease before undergoing 
soft baking and pre-baking. The wafers were exposed to UV light through the shadow 
mask to cross-link the structure of the microchannels prior to post exposure baking. 
Because the microfluidic device is to be multilayer in support of maintaining desired 
fluid dynamics, the process of spin coating, baking, and exposure was repeated to create a 
deeper set of channels. The SU-8 patterns on the substrate were developed in SU-8 
developer (Microchem) for 10 min, rinsed with IPA (isopropyl alcohol) and dried using 
nitrogen gas. Once this master was fabricated, PDMS was poured onto the silicon 
substrate and cured at 90 
o
C. The cured PDMS was peeled off, producing the pattern of 
microfluidic channels that was used in the experiment. The PDMS pattern was cleaned 
and treated with oxygen plasma for 40 seconds before being aligned under the 
microscope using methanol to slow the bonding process. The microfluidic device was 
heated at ~115 
o
C for 24 hours to ensure hydrophobicity. 
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Experimental Procedure 
Syringe pumps were used to drive the injection of the continuous phase (mineral 
oil + Ca) and dispersed phases (alginate and HEPM stem cells + collagen) into the 
microfluidic system. A schematic of the flow-focusing microfluidic device is shown in 
Figure 1 below. The solution of collagen and HEPM stem cells suspended in 0.3 M 
Mannitol + HEPES and 1% cellulose were flowed from the innermost inlet, 2% alginate 
in 0.3 M Mannitol + HEPES was flowed from the middle inlet, and emulsified mineral 
oil infused with calcium ions was flowed from the outermost inlet. The microfluidic 
device was linked to syringes via polytetrafluoroethylene (PTFE) tubing before the 
experiments commenced. The dispersed phase was sheared by the incoming continuous 
(oil) phase to create microcapsules from the differences in surface tensions while 
simultaneously gelling the alginate shell to leave the collagen + HEPM stem cell core. 
After running the experiment at 4 
o
C to ensure the fluidity of collagen, the microcapsules 
were exposed to room temperature to allow collagen to polymerize. The cells were then 
stained with calcein-am and ethidium homodimer to determine cell viability. 
                   
Figure 1: Schematic of flow-focusing, core-shell microfluidic device 
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Chapter 4: Results 
Core-Shell Microcapsule Confirmation 
 Experiments were run to confirm the fabricated multilayer microfluidic device 
created core-shell microcapsules that have potential to hold biocompatible matrices in 
their cores. Mineral oil + calcium was flowed from the outermost inlet, 2% alginate 
solution stained with FITC labeled IgG (immunoglobulin G) was run through the middle 
inlet, and 1% cellulose solution was flowed from the innermost inlet. Figure 2 below 
depicts a time lapse of microcapsule formation and a “z”-stack compilation of 10X 
fluorescent images confirming the creation of an alginate shell and cellulose core.  
 
      
Figure 2: Core-shell microcapsule formation 
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Core-Shell Microcapsules of Varying Stiffness 
 Core-shell microcapsules of varying stiffness were created by flowing collagen 
concentrations of 0.5 mg/mL, 1.5 mg/mL, and 3.0 mg/mL into the innermost inlet (core) 
of the microfluidic device. Figure 3 below compares the morphology of the microcapsule 
cores with core stiffness and depicts the confirmation of varying collagen fiber structure, 
shown in green, using confocal reflectance microscopy.  
            
 
Figure 3: Varying collagen density/stiffness in microcapsule core 
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Control Culture of HEPM Stem Cells in 3D Collagen Matrix 
 A control experiment was conducted to observe the proliferation of HEPM stem 
cells in varying 3D collagen matrices. Films of 1% alginate and 1 mg/mL collagen were 
created on the bottom of a 24-well plate. Different cell suspensions were administered to 
the wells consisting of 0.5 mg/mL, 1.5 mg/mL, or 3.0 mg/mL collagen concentration, 
each holding a cell density of 2.5x10
6
 HEPM stem cells/mL. Figure 4 below depicts the 
HEPM stem cells in varying 3D collagen matrices on day 0 and live(green)/dead(red) 
staining after 3 days of culture. The cells were highly viable and spread out presumably 
by attaching to the matrix of collagen at 1.5 and 3 mg/ml. Also, the matrices of higher 
collagen concentration began aggregating and were no longer homogenous after 3 days.  
 
        
Figure 4: Control of HEPM stem cell attachment in varying 3D collagen matrices 
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Encapsulation of HEPM Stem Cells in 3D Collagen Cores 
 HEPM stem cells were encapsulated in 3D matrix cores with a collagen 
concentration of 3 mg/mL and cell concentration of 2.5x10
6
 HEPM stem cells/mL. 
Mineral oil + calcium was flowed at 4 mL/hr, 2% alginate solution was flowed at 220 
μL/hr, and cell + collagen suspension was flown through a 120 μm wide channel at 150 
μL/hr to produce core-shell microcapsules of < 200 μm diameter. Figure 5 below depicts 
HEPM stem cell proliferation inside the 3D collagen core of the microcapsules after 1, 3, 
and 6 days of culture. 
  
 
Figure 5: Culture of 2.5x10
6 
HEPM stem cells/mL in 3 mg/mL core-shell microcapsules 
of < 200 μm diameter 
  
 HEPM stem cells were then encapsulated in 3D matrix cores with a collagen 
concentration of 3 mg/mL and cell concentration of 2.0x10
6
 HEPM stem cells/mL. 
Mineral oil + calcium was flown at 2 mL/hr, 2% alginate solution was flown at 100 
μL/hr, and cell + collagen suspension was flown through a 200 μm wide channel at 80 
μL/hr to produce core-shell microcapsules of ~ 300 μm diameter. Figure 6 below depicts 
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the HEPM stem cell proliferation inside the 3D collagen core of the microcapsules at day 
0 and after 1 day of culture. Cell viability after encapsulation exceeded 90%. 
 
            
Figure 6: Culture of 2.0 x10
6 
HEPM stem cells/mL in 3 mg/mL core-shell microcapsules 
of ~300 μm diameter 
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Chapter 5: Discussion 
 
A multilayer, flow-focusing microfluidic device was fabricated that successfully 
creates core-shell microcapsules. The contents of these core-shell microcapsules can be 
substituted to create a wide range of biocompatible matrices for different cell types. In 
this study, microcapsules with cores of varying collagen density were created. It is 
evident that the core becomes less pronounced as collagen concentration increases. This 
is likely due to the increased diffusion of collagen into the alginate shell that occurs as a 
result of the delay between microcapsule collection in 4 
o
C and microcapsule exposure to 
room temperature. Confocal reflectance images confirm the increased density of collagen 
in the core as collagen concentration increases and, thus, modulus of elasticity increases 
to create a stiffer 3D matrix for prospective cells. 
The extension of HEPM stem cells into their collagen environment was illustrated 
in a control experiment using a flat, 3D matrix. It is evident that cell structure is similar in 
all collagen matrices on day 0, while dark hashes of collagen fibers are more apparent in 
matrices of higher collagen concentrations. However, day 3 shows increased HEPM stem 
cell spreading in the stiffer 3 mg/mL collagen matrix compared to the 1.5 mg/mL matrix. 
HEPM stem cell spreading in the 0.5 mg/mL collagen matrix is virtually non-existent, 
with more cell death incurred, likely, to the low matrix stiffness. After 3 days, the higher 
collagen concentration matrices were no longer homogenous as they were at day 0. 
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Collagen aggregations formed as HEPM stem cells reached out into their environments to 
modify the matrix by drawing collagen fibers closer to accommodate proliferation and 
migration. 
 HEPM stem cells were encapsulated in 3 mg/mL collagen matrix cores of various 
sized microcapsules. Samples with cell concentrations of 2.5x10
6
 HEPM stem cells/mL 
inside the 3D collagen core of < 200 μm diameter microcapsules after 1, 3, and 6 days of 
culture showed no apparent proliferation. However, it was found that samples with cell 
concentrations of 2.0x10
6
 HEPM stem cells/mL began spreading and proliferating inside 
the 3D collagen core of ~ 300 μm diameter microcapsules after only 1 day. This is likely 
due to the increased space available for HEPM stem cell spreading and decreased 
competition for collagen. The amount of collagen in the microcapsule is finite, however, 
and the cells are not free to optimize their surrounding collagen concentration in support 
of spreading and proliferating as they were in the control experiment. Though the cell 
concentration was decreased, there likely exists some competition for collagen. 
 Future steps include increasing and optimizing microcapsule size and initial 
collagen concentration. This will allow for more cell spreading and proliferation and less 
competition in order for the HEPM stem cells to more closely mimic in-vivo behavior and 
function. Temperature control adjustments will be made to heat the collection as to 
minimize the amount of collagen diffusion into the alginate shell. Once the proliferation 
of HEPM stem cells in the core-shell microcapsules is optimized, differentiation studies 
will take place to develop osteoblast cell lines from the HEPM cells in the collagen 
matrix for hard bone regeneration to treat musculoskeletal diseases. Therefore, these stem 
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cell laden microcapsules show great promise for cell-based therapy and regenerative 
medicine applications. 
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